Compare LNKB & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LNKB | AEF |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.2M | 315.9M |
| IPO Year | 2022 | N/A |
| Metric | LNKB | AEF |
|---|---|---|
| Price | $8.30 | $6.90 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 91.2K | ★ 194.2K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | 3.61% | ★ 7.13% |
| EPS Growth | ★ 26.76 | N/A |
| EPS | ★ 0.90 | 0.57 |
| Revenue | ★ $186,504,000.00 | N/A |
| Revenue This Year | $10.18 | N/A |
| Revenue Next Year | $9.33 | N/A |
| P/E Ratio | ★ $9.22 | $12.14 |
| Revenue Growth | ★ 11.29 | N/A |
| 52 Week Low | $6.09 | $4.43 |
| 52 Week High | $9.59 | $8.93 |
| Indicator | LNKB | AEF |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 31.89 |
| Support Level | $8.07 | $6.69 |
| Resistance Level | $9.02 | $7.20 |
| Average True Range (ATR) | 0.21 | 0.20 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 49.06 | 2.88 |
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.